The distribution of cocaine-and amphetamine-regulated transcript-like immunoreactivity (CART-LI) was investigated in the rat spinal cords with the use of an antiserum against the CART peptide fragment 55±102. CART-LI ®bers were concentrated in the super®cial layers of the dorsal horn of all segments. In addition to CART-LI ®bers, intensely labeled somata were detected in the intermediolateral cell column (IML) and other sympathetic preganglionic nuclei of the thoracolumbar segments. In the lumbosacral segments, CART-LI ®bers but not somata were seen in the sacral parasympathetic nucleus. Double-labeling the spinal sections with choline acetyltransferase (ChAT)-antisera and CARTantisera revealed that the large majority of ChAT-positive somata in the sympathetic preganglionic nuclei were CARTpositive, whereas ChAT-positive somata in the parasympathetic preganglionic nuclei were CART-negative. Our results show that CART-LI is selectively expressed in a population of sympathetic preganglionic neurons (SPNs), but not in parasympathetic preganglionic neurons (PPNs) of the rat. q
Cocaine-and amphetamine-regulated transcript (CART) was ®rst identi®ed in the rat striatum where the levels were up-regulated following acute administration of cocaine and amphetamine [2] . Immunohistochemical and in situ hybridization studies have since revealed an extensive distribution of CART-like immunoreactivity (LI) and mRNA in the rat brain, pituitary and adrenal medulla [1,6±8] . Western blot analysis of rat tissues indicates that there are at least six different CART peptides whose molecular weights vary from 4±14 kDa [9] . The higher molecular weight peptides are thought to be preproCART and proCART; whereas, the lower molecular weight peptides CART 55±102 and CART 62±102 may be the physiologically active fragments [8, 9] .
In the rat spinal cord, CART-LI is concentrated in networks of ®bers in lamina I and II of the dorsal horn, and in neurons of the intermediolateral cell column (IML) of the thoracolumbar segments [5, 7] . However, the distribution of CART-LI in the parasympathetic preganglionic nuclei of the lumbosacral segment has yet to be investigated. The present study was undertaken to address this issue.
Adult male and female Sprague±Dawley rats, weighing 200±250 g, from Harlan (Indianapolis, IN) were used in these studies. Experimental protocols were approved by the University Committee on Animal Care.
Rats were anesthetized with urethane (1.2 g/kg, i.p.) and perfused intracardially with chilled 0.1 M phosphatebuffered saline (PBS) followed by freshly prepared 4% paraformaldehyde in PBS. Spinal cords were removed, post®xed in the same ®xative for 2 h, and stored in 30% sucrose/ PBS solution overnight. Transverse or horizontal 40 mm spinal cord sections were prepared by a Vibratome and processed for CART-LI using the avidin-biotin complex method as described previously [3, 4] . Sections were ®rst treated with 3% H 2 O 2 to quench endogenous peroxidase, washed and blocked with 10% normal goat sera, and incubated with CART-antisera (10 000±16 000 dilution with 0.4% Triton X-100 and 1% bovine serum albumin in PBS; Phoenix Pharmaceuticals, Inc.). The CART-antiserum, a rabbit polyclonal directed against the peptide fragment 55±102, exhibits 100% cross-reactivity with the CART peptide (Phoenix Pharmaceuticals, Inc.). Two sets of control experiments were performed. First, the primary antisera were omitted from the staining procedures. Second, sections were processed with CART-antisera pre-absorbed with the CART peptide 55±102 (10 mg/ml, Phoenix Pharmaceuticals, Inc.) overnight. Several thoracolumbar and lumbosacral sections from each rat were set aside for double-labeling experiments in which sections were incubated sequentially with choline acetyltransferase (ChAT)-antisera and CARTantisera from different hosts, as described previously [3] . Goat polyclonal ChAT-antisera were from Chemicon International, Inc. (Temecula, CA). Sections were ®rst processed for ChAT-LI by incubating in ChAT-antisera (1:300 with 0.4% Triton X-100), later in biotin and then avidin¯uores-cein D. The second step involved the incubation of tissue sections in CART-antisera (1:1000 with 0.4% Triton X-100), biotin and avidin Texas Red.
The spinal cords from nine rats were processed for CART-LI. Approximately 20 transverse sections of cervical, thoracic, lumbar and sacral spinal segments from six rats and several horizontal sections from three rats were examined. The pattern of distribution of CART-LI in the spinal cord of male (n 6) and female (n 3) rats was similar. A feature common to all the segments was the presence of fairly dense networks of CART-LI ®bers in laminae I and II of the dorsal horn; the deeper laminae and ventral horn exhibited much fewer CART-LI ®bers (Fig. 1A,C) . A few labeled somata of small diameter (,10 mm) were scattered throughout the dorsal horn.
CART-LI somata were conspicuously present in the IML of thoracolumbar segments (Figs. 1A,B, 2A,B and 3A,B) . Labeled somata were also seen in other autonomic nuclei including the intermediomedial nucleus and central autonomic nucleus (Figs. 1±3) . In the transverse sections, CART-LI cell processes extended medially toward the central canal, as described for rat sympathetic preganglionic neurons (SPNs) intracellularly labeled with lucifer yellow [11] . In the horizontal sections, labeled SPNs and cell processes were arranged in a ladder-like network between the lateral horn and central canal (Fig. 2) .
With respect to the rat lumbosacral cord, CART-LI somata were not detected in the parasympathetic preganglionic nuclei (Figs. 1C,D, 2C,D and 3C,D) . Instead, CART-LI ®bers were present in the parasympathetic preganglionic nuclei and around the central canal (Figs. 1C and  2D ). The lack of CART-LI somata in the parasympathetic preganglionic nuclei was clearly evident in the horizontal sections (Fig. 2C,D) .
In control sections processed with CART-antisera preabsorbed with the peptide overnight, immunoreactivity was not seen in any of the spinal sections (not shown, see Ref. [3] ).
In the case of thoracolumbar sections double-labeled with ChAT-and CART-antisera, the large majority of ChAT-LI somata in the IML of thoracolumbar segments were CARTpositive and vice versa. A few ChAT-LI somata were CART-negative, whereas some CART-positive neurons were ChAT-negative (Fig. 3A,B) . Ventral horn ChAT-LI neurons were CART-negative (Fig. 3A,B) . There was no evidence of CART-LI in ChAT-positive neurons in the parasympathetic preganglionic nuclei of lumbosacral sections from any of the rats (Fig. 3C,D) .
The present study con®rms and extends the earlier observations relative to the distribution of CART-LI in the rat spinal cord [5, 7] . The CART-antisera used in our study were directed against the CART peptide 55±102 , whereas the CART-antisera used in an earlier study were raised against the peptide 106±129 [7] . The distribution of CART-LI in the rat brain and spinal cord as revealed by these two different antisera was similar [5, 7] . Further, CART-LI was not detected in spinal sections incubated in CART-antisera pre-absorbed with the peptide, attesting to the speci®city of the antisera used in our study.
As noted in the earlier study [5, 7] , CART-LI ®bers were present throughout the gray matter, with the highest concentration in the super®cial layers of the dorsal horn. Insofar as the somata are concerned, a few smaller diameter CART-LI neurons were scattered in the dorsal horn. The biological action of CART on dorsal horn neurons remains to be fully explored. Initial studies showed that an intrathecal administration of CART decreases hindpaw withdrawal latency in the mice, suggesting that the peptide may sensitize dorsal horn neurons to thermal stimuli [10] .
The most conspicuous group of CART-LI cell bodies in the spinal cord is found in the lateral horn of the thoracolumbar cord. On the basis of their location, morphology and co-expression of ChAT-LI, the CART-LI neurons in the IML are presumed to be SPNs. On the other hand, CART-LI was not detected in ChAT-positive neurons of the parasympathetic preganglionic nuclei of the lumbosacral cord. Interestingly, ChAT-positive ventral horn neurons were CART-negative as well. The lack of expression of CART-LI in parasympathetic preganglionic neurons (PPNs) and ventral horn neurons, as revealed by our antisera, is probably not due to the presence of a different form of CART peptide, because CART mRNA is reported to be absent in the rat lumbar and sacral cord by in situ hybridization [1] .
Projecting to different peripheral target ganglion cells notwithstanding, SPNs in the thoracolumbar and PPNs in the lumbosacral cord are not known to differ with respect to their transmitter phenotypes. Both types of neurons are cholinergic and their axons release acetylcholine as the principal transmitter. Viewed in this context, our results provide the ®rst evidence that CART peptide is selectively expressed in SPNs but not in PPNs.
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